Michele De Palma, Ph.D.« Back
Michele De Palma, Ph.D. is an assistant professor at the Swiss Institute for Experimental Cancer Research (ISREC), Swiss Federal Institute of Technology Lausanne (EPFL). His current research interests focus is on how macrophages modulate tumor responses to anticancer therapies. Dr. De Palma has received several awards from the American and European Societies of Gene and Cell Therapy and the European Research Council, and he is an editorial board member of several international journals and is routinely invited to major conferences on inflammation, angiogenesis and cancer. Michele received his Ph.D. from the University of Turin Medical School, where he studied the contribution of monocytes to tumor angiogenesis. He performed post-doctoral training at the San Raffaele Institute (HSR) in Milan to develop new strategies to target biotherapeutics to tumors using engineered monocytes.